Creades AB Ret. on equity
What is the Ret. on equity of Creades AB?
The Ret. on equity of Creades AB is -33.34%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Miscellaneous sector on LSE compared to Creades AB
What does Creades AB do?
Creades AB is a private equity and venture capital investment firm specializing in seed/startup, early, mid & late venture, emerging growth, middle market, growth capital and buyout investments. The firm typically invests in small and medium-sized public and private companies. It focuses on Swedish companies. The firm seeks to invest between SEK100 ($15.51 million) and SEK300 million ($46.53 million). The firm prefers to take a majority stake and seat on the board of directors of its portfolio companies. The firm uses personal and balance sheet capital for making investments. Creades AB was founded in 2011 and is based in Stockholm, Sweden.
Companies with ret. on equity similar to Creades AB
- Ovid Therapeutics Inc has Ret. on equity of -33.40%
- Sparkle Roll has Ret. on equity of -33.36%
- Klimat X Developments Inc has Ret. on equity of -33.36%
- Aphria has Ret. on equity of -33.36%
- Dev Clever Plc has Ret. on equity of -33.34%
- Paragon 28 has Ret. on equity of -33.34%
- Creades AB has Ret. on equity of -33.34%
- China Metal Resources Utilization has Ret. on equity of -33.33%
- Aldeyra Therapeutics Inc has Ret. on equity of -33.33%
- San Lorenzo Gold has Ret. on equity of -33.32%
- Pistol Bay Mining has Ret. on equity of -33.26%
- OrganiMax Nutrient has Ret. on equity of -33.24%
- Atea Pharmaceuticals has Ret. on equity of -33.24%